Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Metastatic Breast Cancer
Trial Locations (24)

1020

CHU Brugmann, Brussels

1070

Erasme, Brussels

1090

UZ Brussel, Brussels

1180

CHIREC - Centre Hospitalier Interrégional Edith Cavell, Brussels

1340

Clinique St Pierre, Ottignies

2020

ZNA Middelheim, Antwerp

2170

ZNA Jan Palfijn, Merksem

2440

AZ St-Dimpna, Geel

2570

AZ St-Maarten, Duffel

2650

UZA, Edegem

2820

Imelda, Bonheiden

2930

AZ KLINA, Brasschaat

4800

CHPLT, Verviers

5000

CHR, Namur

CMSE, Namur

5004

Clinique Saint-Luc, Bouge

5530

CHU Mont-Godinne, Yvoir

6460

CSF, Chimay

6700

Cliniques du Sud Lux - St Joseph, Arlon

7500

Centre Hospitalier de Wallonie picarde - site IMC, Tournai

8000

AZ St Jan, Bruges

8400

AZ Damiaan, Ostend

9000

AZ St-Lucas, Ghent

9100

AZ Nikolaas, St-Niklaas

All Listed Sponsors
lead

Teva Pharma

INDUSTRY

NCT01555944 - Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines | Biotech Hunter | Biotech Hunter